<DOC>
<DOCNO>EP-0621282</DOCNO> 
<TEXT>
<INVENTION-TITLE>
3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31726	C07H1300	A61K3170	A61K31737	C07H1304	C07H1100	C07H310	A61P700	A61P702	C07H1500	A61K31702	A61K317028	A61K31737	C07H300	C07H306	A61K317028	A61K31726	C07H1100	A61K3170	A61K31702	C07H304	C07H1504	C07H308	C07H1308	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07H	A61K	A61K	C07H	C07H	C07H	A61P	A61P	C07H	A61K	A61K	A61K	C07H	C07H	A61K	A61K	C07H	A61K	A61K	C07H	C07H	C07H	C07H	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	C07H13	A61K31	A61K31	C07H13	C07H11	C07H3	A61P7	A61P7	C07H15	A61K31	A61K31	A61K31	C07H3	C07H3	A61K31	A61K31	C07H11	A61K31	A61K31	C07H3	C07H15	C07H3	C07H13	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to 3-deoxyoligosaccharides of formula I: 
<
IMAGE
>
  in which,   - X represents a radical -OSO
<
-
>
3, a radical of formula R-O, a radical of formula 
<
IMAGE
>
  or a radical of formula, 
<
IMAGE
>
     - Y represents a radical of formula: 
<
IMAGE
>
     - R represents an alkyl radical, - R1, R3, R5, R7, R8, R10, R12 and R13, represent a hydroxyl radical, an alkoxy radical or a radical -OSO
<
-
>
3, - R2, R4, R6, R9 and R11, represent a hydrogen atom, a hydroxyl radical, an alkoxy radical or a radical -OSO
<
-
>
3, provided however that at least R2 or R4 or R6 or R9 or R11, represents a hydrogen atom, and their salts with a pharmaceutically acceptable base.I
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
AKZO NOBEL NV
</APPLICANT-NAME>
<APPLICANT-NAME>
SANOFI SA
</APPLICANT-NAME>
<APPLICANT-NAME>
AKZO NOBEL N.V.
</APPLICANT-NAME>
<APPLICANT-NAME>
SANOFI
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
JAURAND GUY FRANCOIS BERNARD
</INVENTOR-NAME>
<INVENTOR-NAME>
PETITOU MAURICE
</INVENTOR-NAME>
<INVENTOR-NAME>
VAN BOECKEL CONSTANT ADRIAAN A
</INVENTOR-NAME>
<INVENTOR-NAME>
JAURAND, GUY FRANCOIS BERNARD
</INVENTOR-NAME>
<INVENTOR-NAME>
PETITOU, MAURICE
</INVENTOR-NAME>
<INVENTOR-NAME>
VAN BOECKEL, CONSTANT ADRIAAN ANTON
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Compounds of formula I 

 
wherein 


X denotes a radical -OSO
3
-
, a radical of formula A, 

R O
 
a radical of formula B, 


 
or a radical of formula C, 


Y represents a radical of formula D, 

R denotes a straight-chained or- branched C
1-6
-alkyl 
radical, 
R
1
, R
3
, R
5
, R
7
, R
8
, R
10
, R
12
 and R
13
, which may be 
identical or different, each represent a hydroxy 

radical, a straight-chained or branched C
1-6
-alkoxy 
radical or a radical -OSO
3
-
, 
R
3
, R
4
, R
6
, R
9
 and R
11
, which may be identical or 
different, each denote a hydrogen atom, a hydroxy 

radical, a straight-chained or branched C
1-6
-alkoxy 
radical or a radical -OSO
3
-
, 
 
   with the proviso that at least one of the 

substituents present, R
2
 or R
4
 or R
6
 or R
9
 or R
11
, 
represents a hydrogen atom,
 
   in the form of pharmaceutically acceptable salts 

and the corresponding acids. 
Compounds of formula I according to claim 1, 
corresponding to formula Ia: 


 
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
11
, R
12
 and R
13
 have 
the same meanings as in formula I, according to claim 1. 
Compounds of formula I according to claim 1, 
corresponding to formula Ib: 


  
 

wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
8
, R
9
, R
10
, R
11
, R
12
 and R
13
 
have the same meaning as in formula I, according to 

claim 1. 
Compounds of formula I according to claim 1, 
wherein 


R
1
, R
3
, R
5
, R
7
, R
8
, R
10
 and R
13
, which may be identical 
or different, each represent a straight-chained or 

branched C
1-6
-alkoxy group or a radical -OSO
3
-
, 
R
2
, R
4
, R
6
 and R
9
, which may be identical or different, 
each denote a hydrogen atom or a straight-chained or 

branched C
1-6
-alkoxy radical, 
R
11
 denotes a hydrogen atom, a straight-chained or 
branched C
1-6
-alkoxy radical or a radical -OSO
3
-
,
 
with the proviso that at least one of the substituents 

present, R
2
 or R
4
 or R
6
 or R
9
 or R
11
, denotes a hydrogen 
atom, and 
R
12
 denotes a hydroxy radical or a radical -OSO
3
-
. 
Compounds of formula I according to claim 1 wherein 
R
2
 denotes a hydrogen atom. 
Compounds of formula I according to claim 1, 
wherein 


R
2
 and R
6
 denote a hydrogen atom, 
R
3
, R
11
 and R
12
 denote a radical -OSO
3
-
, and 
R
13
 denotes a straight-chained or branched C
1-6
-alkoxy 
radical. 
Methyl O-(3-deoxy-2,4,6-tri-sulfo-α-D-
ribo
-hexaopyranosyl)-(1→4)-O-(3-deoxy-2-O-sulfo-β-D-
ribo
-hexopyranosyluronate)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glucopyranosyi)-(1→4)-O-(3-deoxy-2-O-sulfo-α-L-
lyxo
-hexopyranosyl-uronate)-(1→4)-2,3,6-tri-O-sulfo-β-D-glucopyranoside, 
compound of formula I, according to 

claim 1 and the pharmaceutically acceptable salts 
thereof with a base. 
Methyl O-(3-deoxy-2,4-di-O-methyl-6-O-sulfo-α-D-
ribo
-hexaopyranosyl)-(1→4)-O-(3-deoxy-2-O-sulfo-β-D-
ribo
-hexopyranosyluronate)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glucopyranosyl)-(1→4)-O-(3-deoxy-2-O-sulfo-α-L-
lyxo
-hexopyranosyl-uronate)-(1→4)-2,3,6-tri-O-sulfo-β-D-glucopyranoside, 
compound of formula I, according to 

claim 1 and the pharmaceutically acceptable salts 
thereof with a base. 
Methyl O-(3-deoxy-4-O-methyl-2,6-di-O-sulfo-α-D-
ribo
-hexaopyranosyl)-(1→4)-O-(3-deoxy-2-O-sulfo-β-D-
ribo
-hexopyranosyluronate)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glucopyranosyl)-(1→4)-O-(3-deoxy-2-O-sulfo-α-L-
lyxo
-hexopyranosyl-uronate)-(1→4)-2,3,6-tri-O-sulfo-β-D-glucopyranoside, 
compound of formula I, according to 

claim 1 and the pharmaceutically acceptable salts 
thereof with a base. 
Process for preparing compounds of formula I 
according to claim 1, characterised in that a compound 

of formula II 

 
wherein  

 

X' represents a chloroacetyloxy radical, a 
levulinyloxy radical, a radical of formula A according 

to formula I in claim 1,
 
a radical of formula B
1
, 

 
or a radical of formula C
1
, 

P
1
, P
2,
 P
3
 and P
5
, which may be identical or different, 
each denote a protecting group such as an acyclic C
1-6
-acyl 
radical, preferably an acetyl radical, an 

aromatic acyl radical, preferably a benzoyl radical, a 
C
2-7
-alc-2-enyl radical, preferably an allyl radical, 
or a benzyl radical, 
P
4
 and P
6
 which may be identical or different, each 
denotes a protecting group such as a C
1-6
-alkyl 
radical, preferably a methyl radical or a benzyl 

radical, 
R
1
', R
5
', and R
8
' which may be identical or different, 
each denote a straight-chained or branched C
1-6
-alkoxy 
radical, an acyclic C
1-6
-acyloxy radical, preferably an 
acetoxy radical, an aromatic acyloxy radical, 

preferably a benzoyloxy radical or a C
2-7
-alc-2-enyloxy 
radical, preferably an allyloxy radical, 
R
7
' and R
10
' which may be identical or different, have 
the meanings given for R
1
' or they represent a 
chloroacetoxy radical or a levulinyloxy radical, and 
R
2
', R
6
' and R
9
' which may be identical or different, 
each represent a hydrogen atom, or have the meanings  

 
given for R
1
', 
 
is reacted with a compound of formula III: 


 
wherein 


P
7
 has the meanings given for P
4
 in formula II, 
P
8
 has the meanings given for P
1
 in formula II, 
R
4
' and R
11
', which may be identical or different, have 
the same meanings as R
2
' in formula II
 
and 
R
3
', R
12
, and R
13
', which may be identical or different, 
have the meanings given for R
1
' in formula II, 
 
   in order to prepare the compounds of formula IV: 


 
wherein 


X'
1
, P
1
, P
2
, P
3
, P
4
, R
1
' and R
2
' have the same meanings 
as in formula II, 
P
7
, R
3
' and R
4
' have the same meanings as in formula 
III, and 
Y' denotes a radical of formula D
1
: 

 
wherein 


P
8
, R
11
', R
12
' and R
13
' have the same meanings as in 
formula III, 
 
   which is then subjected to catalytic hydrogenation  

 
followed by saponification and sulfatation, or first to 

saponification and then to sulfatation and finally to 
catalytic hydrogenation, or first to catalytic 

hydrogenation then sulfatation and finally 
saponification, to obtain the compounds of formula I. 
Process for preparing the compounds of formula I 
according to claim 1, characterised in that a 

monosaccharide containing protecting groups on the 
hydroxy radical and possibly on the carboxyl radicals if 

it has any, is reacted with another protected 
monosaccharide, to form a disaccharide with which 

another protected monosaccharide is subsequently 
reacted, to form a protected trisaccharide, from which a 

protected tetrasaccharide can be obtained followed by a 
protected pentasaccharide and, subsequently, a protected 

hexasaccharide, the said tetra-, penta- or 
hexasaccharides subsequently being deprotected and 

possibly sulfated or first of all partly deprotected, 
then sulfated and then deprotected. 
Compounds of formula I according to any one of 
claims 1 to 9 for use as a medicament. 
Pharmaceutical compositions containing as active 
principle a compound according to any one of claims 1 to 

9, or one of the salts thereof with a pharmaceutically 
acceptable base, combined or admixed with an inert, non 

toxic, pharmaceutically acceptable excipient. 
1,6;2,3 di-anhydro-4-O-(2,4,6-tri-O-benzoyl-3-deoxy-β-D-
ribo
-hexopyranosyl)-β-D-mannopyranose, 
compound of formula IX: 


  
 

wherein Bz denotes a benzoyl radical. 
1,6:2,3 di-anhydro-4-O-(3-deoxy-β-D-
ribo
-hexopyranosyl)-β-D-mannopyranose, 
compound of formula X: 


Compounds of formula XI: 

 
wherein 


R
1
' denotes a straight-chained or branched C
1-6
-alkoxy 
radical, a C
1-6
-acylic acyloxy radical, preferably an 
acetoxy radical, an aromatic acyloxy radical, 

preferably a benzoyloxy radical or a C
2-7
-alc-2-enyloxy 
radical, preferably an allyloxy radical, 
P
1
 and P
2
 which may be identical or different, each 
denote a protecting group selected from an acyclic C
1-6
-acyl 
radical, preferably an acetyl radical, an 

aromatic acyl radical, preferably a benzoyl radical, a 
C
2-7
-alc-2-enyl radical, preferably an allyl radical or 
a benzyl radical, 
P
4
 denotes a protecting group selected from a C
1-6
-alkyl 
radical, preferably a methyl radical or a benzyl 

radical, and 
P
9
 denotes a levulinyl radical or a chloroacetyl 
radical. 
</CLAIMS>
</TEXT>
</DOC>
